Ring BJ - Search Results

1

In vitro interaction of the antipsychotic agent olanzapine with human cytochromes P450 CYP2C9, CYP2C19, CYP2D6 and CYP3A.

Ring BJ, Binkley SN, Vandenbranden M, Wrighton SA. Ring BJ, et al. Br J Clin Pharmacol. 1996 Mar;41(3):181-6. doi: 10.1111/j.1365-2125.1996.tb00180.x. Br J Clin Pharmacol. 1996. PMID: 8866916 Free article.

2

Atomoxetine hydrochloride: clinical drug-drug interaction prediction and outcome.

Sauer JM, Long AJ, Ring B, Gillespie JS, Sanburn NP, DeSante KA, Petullo D, VandenBranden MR, Jensen CB, Wrighton SA, Smith BP, Read HA, Witcher JW. Sauer JM, et al. J Pharmacol Exp Ther. 2004 Feb;308(2):410-8. doi: 10.1124/jpet.103.058727. Epub 2003 Nov 10. J Pharmacol Exp Ther. 2004. PMID: 14610241

3

Identification of the human cytochromes P450 responsible for atomoxetine metabolism.

Ring BJ, Gillespie JS, Eckstein JA, Wrighton SA. Ring BJ, et al. Drug Metab Dispos. 2002 Mar;30(3):319-23. doi: 10.1124/dmd.30.3.319. Drug Metab Dispos. 2002. PMID: 11854152

4

The interactions of a selective protein kinase C beta inhibitor with the human cytochromes P450.

Ring BJ, Gillespie JS, Binkley SN, Campanale KM, Wrighton SA. Ring BJ, et al. Drug Metab Dispos. 2002 Sep;30(9):957-61. doi: 10.1124/dmd.30.9.957. Drug Metab Dispos. 2002. PMID: 12167559

5

Effect of tadalafil on cytochrome P450 3A4-mediated clearance: studies in vitro and in vivo.

Ring BJ, Patterson BE, Mitchell MI, Vandenbranden M, Gillespie J, Bedding AW, Jewell H, Payne CD, Forgue ST, Eckstein J, Wrighton SA, Phillips DL. Ring BJ, et al. Clin Pharmacol Ther. 2005 Jan;77(1):63-75. doi: 10.1016/j.clpt.2004.09.006. Clin Pharmacol Ther. 2005. PMID: 15637532 Clinical Trial.

6

Effect of dirithromycin on human CYP3A in vitro and on pharmacokinetics and pharmacodynamics of terfenadine in vivo.

Goldberg MJ, Ring B, DeSante K, Cerimele B, Hatcher B, Sides G, Wrighton S. Goldberg MJ, et al. J Clin Pharmacol. 1996 Dec;36(12):1154-60. doi: 10.1002/j.1552-4604.1996.tb04170.x. J Clin Pharmacol. 1996. PMID: 9013373 Clinical Trial.

7

In vitro methods for assessing human hepatic drug metabolism: their use in drug development.

Wrighton SA, Vandenbranden M, Stevens JC, Shipley LA, Ring BJ, Rettie AE, Cashman JR. Wrighton SA, et al. Among authors: ring bj. Drug Metab Rev. 1993;25(4):453-84. doi: 10.3109/03602539308993982. Drug Metab Rev. 1993. PMID: 8313838 Review. No abstract available.

8

Effect of fluoxetine, norfluoxetine, sertraline and desmethyl sertraline on human CYP3A catalyzed 1'-hydroxy midazolam formation in vitro.

Ring BJ, Binkley SN, Roskos L, Wrighton SA. Ring BJ, et al. J Pharmacol Exp Ther. 1995 Dec;275(3):1131-5. J Pharmacol Exp Ther. 1995. PMID: 8531073

9

Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine.

Ring BJ, Catlow J, Lindsay TJ, Gillespie T, Roskos LK, Cerimele BJ, Swanson SP, Hamman MA, Wrighton SA. Ring BJ, et al. J Pharmacol Exp Ther. 1996 Feb;276(2):658-66. J Pharmacol Exp Ther. 1996. PMID: 8632334

10

Interaction of human liver cytochromes P450 in vitro with LY307640, a gastric proton pump inhibitor.

VandenBranden M, Ring BJ, Binkley SN, Wrighton SA. VandenBranden M, et al. Among authors: ring bj. Pharmacogenetics. 1996 Feb;6(1):81-91. doi: 10.1097/00008571-199602000-00007. Pharmacogenetics. 1996. PMID: 8845864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page